Are biologics for chronic rhinosinusitis effective and safe?-Reference-Cited by-同舟云学术

Are biologics for chronic rhinosinusitis effective and safe?

Published:2021-06-11 Issue:7 Volume:51 Page:870-872
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Rampersad Anjali¹^ORCID,Banerjee Nandini²,Hinks Timothy S. C.³^ORCID

Affiliation:

1. Imperial College NHS Healthcare Trust London UK

2. Addenbrooke’s Hospital Cambridge UK

3. Respiratory Medicine Unit and National Institute for Health Research (NIHR), Oxford Biomedical Research Centre (BRC) Nuffield Department of Medicine Experimental Medicine University of Oxford Oxford UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13904

Reference6 articles.

1. SedaghatAR.Chronic rhinosinusitis.Infections of the Ears Nose Throat and Sinuses.2018:155‐168.

2. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps

3. Anti-IgE (omalizumab): A new therapeutic approach for chronic rhinosinusitis

4. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study

5. Joint Formulary Committee.British National Formulary (online). London: BMJ Group and Pharmaceutical Press.http://www.medicinescomplete.com. Accessed on 11th May; 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features of responders to mepolizumab in eosinophilic chronic rhinosinusitis and the outcomes post treatment cessation;Australian Journal of Otolaryngology;2024-04

2. Erratum;Clinical & Experimental Allergy;2022-01